Body

Vitamin E may increase the life expectancy of restricted groups of men

Depending on the level of smoking and dietary vitamin C intake, vitamin E supplementation may extend the life-span of restricted groups of men, according to a study published in the Age and Ageing.

Several large randomized trials of humans found that vitamin E supplementation does not reduce mortality. However, the average effect on mortality in a group of people with a wide age range may mask an effect of vitamin E on the life-span.

How much sex is enough?

Society has long debated the contrasting advantages of monogamy and promiscuity and, in western society at least, the long term benefits of monogamy have in general won out. However new research published in BioMed Central's open access journal BMC Evolutionary Biology shows that sperm from polygamous mice are better competitors in the race for fertilisation.

Bedbug genetic study finds possible pesticide-resistance genes

Ohio State University entomologists have conducted the first genetic study of bedbugs, paving the road to the identification of potential genes associated with pesticide resistance and possible new control methods for the troublesome insect, whose sudden resurgence in the United States has led to a public health scare.

The discovery was reported Jan. 19 in the online journal PLoS ONE.

A nanoscale rope, and another step toward complex nanomaterials that assemble themselves

Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have coaxed polymers to braid themselves into wispy nanoscale ropes that approach the structural complexity of biological materials.

Their work is the latest development in the push to develop self-assembling nanoscale materials that mimic the intricacy and functionality of nature's handiwork, but which are rugged enough to withstand harsh conditions such as heat and dryness.

Science Translational Medicine: 'Creating Hope Act' incentivizes pediatric drug RD

Washington, DC — Recent legislative and regulatory actions make great strides toward establishing much needed incentives for pharmaceutical companies and others to develop and test more medications for pediatric rare diseases, including pediatric cancers, according to commentary by experts from Children's National Medical Center.

University of Illinois study confirms glycerin as a feasible feedstuff for swine

University of Illinois study confirms glycerin as a feasible feedstuff for swine

An increased interest in biofuel production and a growing need to find cost-effective livestock feedstuff alternatives has led University of Illinois researchers to further evaluate the use of glycerin in swine diets.

Like humans, amoebae pack a lunch before they travel

Like humans, amoebae pack a lunch before they travel

Some amoebae do what many people do. Before they travel, they pack a lunch.

Small molecules may prevent ebola infection

Ebola, a virus that causes deadly hemorrhagic fever in humans, has no known cure or vaccine. But a new study by University of Illinois at Chicago scientists has uncovered a family of small molecules which appear to bind to the virus's outer protein coat and may inhibit its entry into human cells.

The results are to be published in the Journal of Medicinal Chemistry and are now online.

Mathematical model explains how complex societies emerge, collapse

Mathematical model explains how complex societies emerge, collapse

The instability of large, complex societies is a predictable phenomenon, according to a new mathematical model that explores the emergence of early human societies via warfare. Capturing hundreds of years of human history, the model reveals the dynamical nature of societies, which can be difficult to uncover in archaeological data.

Roundworm unlocks pancreatic cancer pathway

Chapel Hill, NC – The National Cancer Institute estimates that more than 43,000 Americans were diagnosed with pancreatic cancer last year and more than 36,000 died from the disease. Despite advances in genetic science showing that the Ras oncogene is mutated in virtually all pancreatic cancers, scientists have been frustrated by the complexity of the signaling pathways in humans, which make it difficult to pinpoint potential therapeutic targets.

MIT scientists discover cancer-fighting role for cells

CAMBRIDGE, Mass. -- MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.

Research provides new kidney cancer clues

Grand Rapids, Mich. (January 19, 2011) – In a collaborative project involving scientists from three continents, researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The gene – called PBRM1 – was found to be mutated in 88 cases out of 257 clear cell renal cell carcinomas (ccRCC) analysed, making it the most prevalent to be identified in renal cancer in 20 years.

Internet-based rehab is a viable treatment option following knee surgery

Knee replacement patients undergoing telerehabilitation – a unique Internet-based postoperative rehabilitation program that can be conducted from the patient's home – experience the same results as patients who undergo traditional postoperative rehabilitation, according to a new study published in the Journal of Bone and Joint Surgery (JBJS). Telerehabilitation is becoming a popular alternative for patients who live in remote areas and who have no access to traditional rehabilitation centers.

UCSF team views genome as it turns on and off inside cells

UCSF researchers have developed a new approach to decoding the vast information embedded in an organism's genome, while shedding light on exactly how cells interpret their genetic material to create RNA messages and launch new processes in the cell.

Research provides new kidney cancer clues

Researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The identification of a frequently mutated gene will provide new insights into the biology of the disease. This biological knowledge will be critical in the continued effort to improve treatment for renal cancer.